mepolizumab  - Drug Details
📊 Estimates mepolizumab  Dialyzability By Different_Modalities

mepolizumab 

Complete Drug Information

Drug Name
mepolizumab 
Trade Names
Nucala
Pregnancy Category
AU: B1
Bioavailability
80% (estimate)
Routes of Administration
Subcutaneous injection
Protein Binding
None%
Metabolism
Proteolytic enzymes
Elimination
20 (16–22) days
Molar Mass
149000
Volume of Distribution
0.055 L/kg

🤰 Pregnancy Category Information

Category: AU: B1

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have not shown evidence of an increased occurrence of fetal damage.